PNC Financial Services Group’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
O
FLAM
AC
KLP
DCM
PNC Financial Services Group's NPCE Position: Q3 2025 in Review
PNC Financial Services Group sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 65 shares — an estimated $724 sold.
PNC Financial Services Group first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $724 in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.
- PNC Financial Services Group reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
- PNC Financial Services Group sold 65 Neuropace shares in Q3 2025, an estimated $724.
- PNC Financial Services Group first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
- PNC Financial Services Group's Neuropace position peaked at $724 in Q2 2025.
- 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.
Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.